Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 3 of the 9 sources its claims cite were checked for support.
Abstract
This study outlines our strategy for constructing a 3D-bioprinted liver, using in vitro-expanded primary hepatocytes recognized for their safety and enhanced functional robustness as hepatic cell sources for bioartificial liver construction... Upon heterotopic transplantation into the mesentery of tyrosinemia or 90% hepatectomy mice, our 3D-bioprinted liver effectively restored lost liver functions...
Overview
CoChat Summary
TL;DR
This study built a 3D-bioprinted liver (“3DP-liver”) from in vitro–expanded primary mouse hepatocytes in a liver decellularized matrix/gelatin/sodium alginate bioink and showed that it can mature in vitro and restore liver function after heterotopic transplantation in mice. In Fah−/− tyrosinemia mice and 90% hepatectomized mice, transplantation improved biochemical liver injury markers and extended survival, and an added artificial blood vessel enabled biomolecule exchange and direct vascular connection in principle.
Key findings
- Primary mouse hepatocytes were expanded for more than 25 generations, with a theoretical cell count exceeding 1 × 10^20; 96.9 ± 1.5% of analyzed eHep cells stained positive for albumin.
- A 5% 3D-DLS gel (liver decellularized matrix + gelatin + sodium alginate) gave the best printing/biocompatibility performance; after 5 days of culture, 23.3 ± 2.4% of eHep cells were Ki67-positive, and cell survival was >99% at 3% and 5% gel concentrations.
- The 3DP-liver showed mature liver functions in vitro, including higher expression of hepatic genes (Alb, Ttr, Trf, Ck18), induction of drug-metabolism genes, CYP1A2 activity, ICG uptake/release, glycogen storage, and ac-LDL uptake.
- In Fah−/− mice, 3DP-liver transplantation reduced serum tyrosine and phenylalanine, lowered injury markers (ALT, AST, TBA, TBIL, DBIL, ALP), increased ALB, improved histology, and prolonged lifespan; in 90% hepatectomized mice, it also significantly extended survival.
- With an artificial blood vessel, Cy7 and glucose diffused through the construct, and the authors report that a vascularized 3DP-liver could be directly connected to rat vessels without observed leakage in their setup.
Methods
- Mouse hepatocytes were isolated from 6- to 8-week-old C57 mice, expanded in hepatocyte expansion medium, and combined with liver decellularized matrix, gelatin, and sodium alginate to make a 3D-DLS bioink for extrusion bioprinting.
- The authors assessed rheology/mechanics, cell viability/proliferation, gene expression (qPCR, RNA-seq), and liver-specific functions in vitro, then transplanted 3DP-liver into the mesentery of mice for in vivo testing.
- In vivo studies used C57BL/6NCrl mice and Fah−/− mice (with NTBC withdrawal) for therapeutic testing, plus a 90% hepatectomy mouse model; survival and serum liver biochemistry were analyzed with t tests/ANOVA.
Limitations
- The authors explicitly note that the artificial blood vessel’s toughness was insufficient in rats, which can cause blood leakage because of active movement, so the vascular fixation/transplantation system needs further refinement.
- The work is a proof-of-principle study in mice and rats; the text does not report human transplantation or long-term human safety, so clinical applicability remains unproven (evident from the models used).
- The paper shows vascular connection “in principle,” but also indicates that the system still requires additional research for stable large-scale transplantation, especially for acute liver failure scenarios (stated and evident from the discussion).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
2 Valid · 1 Not valid · 6 Not checked · 93 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Prkaca, Prkacb, and Prkx, the adenosine 3′,5′-monophosphate (cAMP)–dependent kinases known for their significant role in hepatocyte maturation, were also notably up-regulated in the 3DP-liver (figs. S5 and S6) (30).”
§ Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes > RESULTS > In vitro liver functions of 3DP-liver
What the sources say
- Could not verifycites [30] Y. Yuan, C. Wang, X. Zhuang, S. Lin, M. Luo, W. Deng, J. Zhou, L. Liu, L. Mao, W. Peng, J. Chen, Q. Wang, Y. Shu, Y. Xue, P. Huang, PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest. Nat. Commun. 13, 5237 (2022). 36068222 PMC9448736 sourceExperimental — accuracy not yet measured
The Results section on cAMP-dependent kinases identifies Prkaca, Prkacb, and Prkx as regulators of hepatocyte maturation in mouse liver-progenitor-derived cells. It does not report whether those genes are up-regulated in 3DP-liver; a search for 3DP-liver and their up-regulation found no supporting passage in our copy. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Commonly used hepatic cell lines, such as HepG2 cell lines, derived from hepatocellular carcinomas, often experience a loss of mature liver functions (31, 32).”
§ Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes > DISCUSSION
What the sources say
- Partly supportedcites [31] X. Ma, C. Yu, P. Wang, W. Xu, X. Wan, C. S. E. Lai, J. Liu, A. Koroleva-Maharajh, S. Chen, Rapid 3D bioprinting of decellularized extracellular matrix with regionally varied mechanical properties and biomimetic microarchitecture. Biomaterials 185, 310– 321 (2018). 30265900 PMC6186504 sourceExperimental — accuracy not yet measured
The Results section ('Photocrosslinked liver dECM-based scaffold supports HCC culture in vitro'; page unavailable) identifies HepG2 as a widely used hepatocellular carcinoma cell line. The Results section on cirrhotic dECM scaffolds (page unavailable) reports reduced liver-specific marker expression only when HepG2 cells were cultured in stiff scaffolds; it does not establish that hepatic cell lines generally or often lose mature liver functions. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [32] S. Hong, J. M. Song, A 3D cell printing-fabricated HepG2 liver spheroid model for high-content in situ quantification of drug-induced liver toxicity. Biomater. Sci. 9, 5939– 5950 (2021). 34318795 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Besides, constructing a large-scale 3DP-liver with a hepatic cell mass resembling that of the native human liver presents challenges in nutrient and oxygen exchange, necessitating vascularization (36).”
§ Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes > DISCUSSION
What the sources say
- Partly supportedcites [36] A. Dellaquila, C. Le Bao, D. Letourneur, T. Simon-Yarza, In vitro strategies to vascularize 3D physiologically relevant models. Adv. Sci. 8, e2100798 (2021). PMC8498873 34351702 sourceExperimental — accuracy not yet measured
The Introduction (page not provided) says oxygen and nutrient diffusion is limited and that thick, metabolically active organs such as the liver require a functional vascular network. The paper also discusses bioprinted hepatic constructs, but it does not specifically address a printed liver with a hepatic cell mass resembling that of a native human liver. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Morphological examination of the 3DP-liver after 5 days revealed that the majority of eHep cells grew in clusters within the porous structure (Fig. 3, G and H).”
§ Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes > RESULTS > Biocompatibility assessment of 3DP-liver
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with prior studies, the 3DP-liver exhibited elevated expression levels of hepatic functional genes, including Alb, Ttr, Trf, and Ck18, when compared to 2D-cultured eHep cells.”
§ Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes > RESULTS > In vitro liver functions of 3DP-liver
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
73 more claims
Create a free account to see all 102 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 18
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deng and colleagues integrated primary hepatocytes into a 3D bioprinted hepatic construct; sustained oxygen and nutrient perfusion promoted rapid proliferation, restored hepatic function, and extended survival in murine liver-failure models [212].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [212]
Citations
Cites
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M. M. A., Ellis, E., van Wenum, M., Fuchs, S. A., de Ligt, J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.050 · Cited by 1,619
Trefts, E., Gannon, M., & Wasserman, D. H. (2017) · Current Biology · doi:10.1016/j.cub.2017.09.019 · Cited by 1,452
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282
Progress in 3D bioprinting technology for tissue/organ regenerative engineering
Matai, I., Kaur, G., Seyedsalehi, A., McClinton, A., & Laurencin, C. T. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119536 · Cited by 1,156
An estimation of the number of cells in the human body
Bianconi, E., Piovesan, A., Facchin, F., Beraudi, A., Casadei, R., Frabetti, F., Vitale, L., Pelleri, M. C., Tassani, S., Piva, F., et al. (2013) · Annals of Human Biology · doi:10.3109/03014460.2013.807878 · Cited by 1,012
Kubes, P., & Jenne, C. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052415 · Cited by 923
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864
Self-citationOpportunities and challenges of translational 3D bioprinting
Murphy, S. V., De Coppi, P., & Atala, A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0471-7 · Cited by 563
Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes
Huang, P., Zhang, L., Gao, Y., He, Z., Yao, D., Wu, Z., Cen, J., Chen, X., Liu, C., Hu, Y., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.003 · Cited by 560
Self-citationGeneration of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids
Mun, S. J., Ryu, J.-S., Lee, M.-O., Son, Y. S., Oh, S. J., Cho, H.-S., Son, M.-Y., Kim, D.-S., Kim, S. J., Yoo, H. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.030 · Cited by 373
Cited by
Engineered Living Systems Based on Gelatin: Design, Manufacturing, and Applications
Wang, Z., Lin, Z., Mei, X., Cai, L., Lin, K., Rodríguez, J. F., Ye, Z., Parraguez, X. S., Guajardo, E. M., Luna, P. C. G., et al. (2025) · Advanced Materials · doi:10.1002/adma.202416260 · Cited by 97
Ge, J.-Y., Wang, Y., Li, Q., Liu, F.-K., Lei, Q.-K., & Zheng, Y. (2024) · PeerJ · doi:10.7717/peerj.18422 · Cited by 31
Bioprinted high cell density liver model with improved hepatic metabolic functions
Lu, T.-Y., Ji, Y., Lyu, C., Shen, E. N., Sun, Y., Xiang, Y., Meng‐Saccoccio, T., Feng, G., & Chen, S. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123256 · Cited by 20
Ma, Y., He, R., Deng, B., Luo, M., Zhang, W., Mao, L., Hu, W., Mao, Y., Yang, H., & Huang, P. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314241313341 · Cited by 16
Self-citationConstructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
Xue, T., Zhang, J., Li, F., Chen, G., Yi, K., Chen, X., Zhang, Y., Xu, Y., Wang, H., Ju, E., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123458 · Cited by 16
Wang, Y., Guo, F., Zhou, M., Wu, Q., You, T., Zhong, Z., Yang, J., Liu, L., Huang, Y., & Wang, M. (2024) · Journal of Materials Chemistry A · doi:10.1039/d4ta05967k · Cited by 8
Self-citation3D bioprinting of tissues and organs for systemic diseases and localized injuries
Ng, W. K., & Bártolo, P. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100006 · Cited by 30
Dahlan, N. A., Chiok, K. L., Tabil, X. L., Duan, X., Banerjee, A., Dhar, N., & Chen, D. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214428 · Cited by 6
Self-Organized Vascularized Hepatic Organoids in Microcapsules for Liver Regeneration
Zhi, Y., Wang, J., Huang, D., & Zhao, Y. (2025) · Research · doi:10.34133/research.0898 · Cited by 14
Self-citationQin, S., Bo, X., Liu, H., Zhang, Z., Zhao, Z., & Xia, Q. (2025) · Hepatology · doi:10.1097/hep.0000000000001321 · Cited by 8
Patel, P. S., Pandey, G., Kumar, A., Misra, S. K., Roy, S., Awasthi, D. A., Wagh, S. S., Srivastava, S., & Kapoor, A. (2026) · Biomedical Materials & Devices · doi:10.1007/s44174-026-00671-8 · Cited by 8
Li, F., Xue, T., Xu, Y., Wang, H., Ju, E., Li, M., & Tao, Y. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123710 · Cited by 4
Saha, R. K., Hassan, M., Ali, M. R., Islam, M. M., & Das, A. (2026) · Biomedical Engineering Advances · doi:10.1016/j.bea.2026.100216 · Cited by 5
Zhao, Y., Li, Y., Zhang, W., Jiang, H., Mao, L., He, R., Ma, Y., Wang, Q., & Huang, P. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000823 · Cited by 5
Self-citationDing, W., Zhou, P., Qiao, Y., Wang, S., Li, X., Wang, H., Li, Y., Zhang, L., Zhou, X., Chen, C. M., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124019 · Cited by 2
Image-guided injectable niche for hepatocyte transplantation
Kumar, V., Yun, J., Elledge, S. K., Henning, N., Grzelak, K. A., Westerfield, A. D., Stoddard, A. E., Oladimeji, F. A., Spanoudaki, V. C., Chakraborty, K., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100378 · Cited by 2
Research insights and clinical opportunities of functional organoid-based platforms
Huang, Y., Shen, W., Li, K., Zhang, Y., Lv, Q., Wang, C., Mao, W., & Zhao, A. (2025) · Bio-Design and Manufacturing · doi:10.1631/bdm.2400519 · Cited by 1
Decellularized Liver Matrix-Based Bioactive Beads Induce Host-Vasculature Integrated Embolization.
Ma, Y., Liu, Z., Yao, F.-B., Huang, M., Li, Y., Shi, P., & Guo, Q.-Y. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.12.042 · Cited by 2
Self-citationYe, Z., Yan, J., Wang, Y., Lin, Y., Wang, C., Yang, Q., Ji, T., Zhou, E., Zheng, Q., Zhong, D., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.12.024 · Cited by 8
Wang, X., Zhang, X., Gu, L., Liang, M., Yao, Y., Jin, Y., & Shao, L. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176083 · Cited by 2
Self-citationEngineering extracellular matrix-based liver hydrogels as advanced bio-mimetic platforms
Wieland, J., Weinhart, M., Papke, B., Käs, J. A., Roth, K., Sack, I., Pratschke, J., Igor, S., Hillebrandt, K. H., & Daneshgar, A. (2026) · npj gut and liver. · doi:10.1038/s44355-026-00073-z · Cited by 1
Li, C., Wang, Z., Sun, M., Yang, J., Qu, H., Xue, Y., & Hu, Y. (2026) · Journal of Applied Biomaterials & Functional Materials · doi:10.1177/22808000261489164
Advances in 3D-bioprinted implantable liver microtissue for liver failure treatment
Lin, Y., Huang, Y., Cheng, D., Li, M., & Tao, Y. (2026) · Chemical Communications · doi:10.1039/d6cc03265f
Developing a Clinically Practical Biomaterial Platform for Endogenous Liver Regeneration
Beamish, C., Abounorinejad, F., Kim, D. K., Tong, A. P., Barri, H., Marx, C., Lane, D., McGregor, H., Laidlaw, G., Jeffries, J., et al. (2026) · Gels · doi:10.3390/gels12050426
Sun, S., Chen, S., Ma, W., Xu, J., Lu, M., & Lu, H. (2026) · Organoids · doi:10.3390/organoids5030026
Li, J. R., Wu, Z., Zhang, Y., Chen, S., Lin, Y., Chen, S., Xu, T., Meng, X., Zhang, Y., & Lin, J. (2026) · Advanced Science · doi:10.1002/advs.76211
Jin, B., Xie, Z., Wang, Y., Lu, Y., Sun, L., He, Z., Ye, Y., Fang, Z., Chi, Y., Pang, M., et al. (2025) · Biofabrication · doi:10.1088/1758-5090/ae288d
Self-citationKamei, K. (2026) · Communications Biology · doi:10.1038/s42003-026-10887-5
Tian, Q., Zhang, H., Hu, Z., Jia, J., Hua, Y., & Wu, Y. (2025) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2025.102054
Can portable artificial livers become an alternative to liver transplantation in the future?
Du, L., Yi, H., Chen, Y., & Xu, H. C. (2025) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-2025-503 · Cited by 1
Kim, Y. S., Han, S. Y., An, S., Lee, M. J., Oh, T.-G., Kim, H. J., Son, M.-Y., & Cho, S. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.09.006
Treatment of liver failure utilizing multi-cell lineage liver microtissue
Chen, M., Wang, H., Zhao, Y., Tao, H., Sharma, A. D., Yuan, Q., Ott, M., Li, W., Lai, L., Song, G., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101864
Self-citationQuarante ans de médecine et de science en hépatologie…
Gilgenkrantz, H., & Rautou, P. (2025) · médecine/sciences · doi:10.1051/medsci/2025126
Cell Sheet Technology as a Platform for Functional Regeneration
Shiota, G., & Itaba, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198695
Xue, T., Zhang, J., Wang, B., Li, F., Chen, G., Xu, Y., Luo, Y., Sun, J., Lao, Y., Wang, J., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.025 · Cited by 1
A Systematic Review on Artificial Liver for Implantation
Le, T. H., Hyun, K., Rezaei, N. T., Nguyen, C. T., Hlabano, S. J., Le, V. P., Kim, K., & Koo, K.-I. (2026) · Journal of Functional Biomaterials · doi:10.3390/jfb17020073
Kong, D., Deng, J., Mao, Q., Zhao, X., Ye, L., Han, L., Zhou, J., & Yang, L. (2026) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1710837 · Cited by 2
(2025) · doi:10.2139/ssrn.5276892
Self-citationBioprinted Advanced Therapeutics: Science, Hurdles, and Regulation
Mansouri, M., Sung, K., Ricles, L. M., & Oh, S. S. (2026) · Springer eBooks · doi:10.1007/978-981-96-7448-0_6-1
Li, A., Chen, D., & Shen, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02948-y · Cited by 1
Li, S., Zheng, T., Li, Y., Wang, X., Jiang, Y., & Huang, P. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166655 · Cited by 2
Self-citationXiu, L., Zhang, J., Bong, W., Jeong, S., Yue, T., Hann, S.-Y., Wang, Y., Cui, H., & Zhang, L. G. (2026) · Small · doi:10.1002/smll.76030
Deng, B., Ma, Y., Huang, W. Y., Xian, X., Ding, Y., Lu, Y., Yang, Y., Guo, W., Mao, L., Wang, X., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed7050
Self-citation
Metadata
- Authors
- Deng, B., Ma, Y., Huang, J., He, R., Luo, M., Mao, L., Zhang, E., Zhao, Y., Wang, X., Wang, Q., Pang, M., Mao, Y., Yang, H., Liu, L., & Huang, P.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Jiangxi Maternal and Child Health Hospital (CN)
- Corresponding author
- Deng, Bo
- Ma, Yue
- Huang, Jialyu
- Yang, Huayu
- Liu, Lanxia
- Huang, Pengyu
- ORCID
- Venue
- Science Advances
- Published
- 2024-06-07
- Volume
- 10
- Issue
- 23
- Pages
- eado1550-eado1550
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC11160470
- OpenAlex
- W4399425544
- Semantic Scholar
- bdcb1be1c1271dd25dad357987fcd420cda80dcf
- Cited by
- 47
- References
- 36
- Citations by year
- 2026: 26 · 2025: 19 · 2024: 2
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Science Advances (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- 3D bioprinting, bioartificial liver, liver failure, primary hepatocytes, hepatocyte expansion, bioinks, heterotopic transplantation, tyrosinemia, artificial blood vessels, vascular integration, liver regeneration
- MeSH terms
- Animals, Disease Models, Animal, Liver, Liver Transplantation, Liver Failure, Liver, Artificial, Tyrosinemias, Hepatocytes, Tissue Engineering, Mice, Tissue Scaffolds, Bioprinting, Printing, Three-Dimensional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.